In a filing, Lilly(Eli) & Co revealed its EVP & President, LLY Int’l Yuffa Ilya unloaded Company’s shares for reported $0.94 million on May 14 ’25. In the deal valued at $749.24 per share,1,250 shares were sold. As a result of this transaction, Yuffa Ilya now holds 27,510 shares worth roughly $20.77 million.
Then, Yuffa Ilya bought 2,500 shares, generating $1,873,100 in total proceeds.
Before that, DONALD ZAKROWSKI bought 2,000 shares. Lilly(Eli) & Co shares valued at $1,643,720 were divested by the Officer at a price of $821.86 per share.
HSBC Securities downgraded its Lilly(Eli) & Co [LLY] rating to a Reduce from a a Buy in a research note published on April 28, 2025; the price target was decreased to $700 from $1150. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Wolfe Research started covering the stock on November 15, 2024. It rated LLY as “an Outperform”.
Price Performance Review of LLY
On Monday, Lilly(Eli) & Co [NYSE:LLY] saw its stock fall -0.30% to $755.11. Over the last five days, the stock has lost -0.06%. Lilly(Eli) & Co shares have fallen nearly -2.19% since the year began. Nevertheless, the stocks have fallen -4.05% over the past one year. While a 52-week high of $972.53 was reached on 03/03/25, a 52-week low of $677.09 was recorded on 04/07/25.
How much short interest is there in Lilly(Eli) & Co?
A steep rise in short interest was recorded in Lilly(Eli) & Co stocks on 2025-04-30, growing by 0.34 million shares to a total of 7.35 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 7.02 million shares. There was a rise of 4.57%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 17, 2024 when Bernstein began covering the stock and recommended ‘”an Outperform”‘ rating along with a $1100 price target.
